Table 3.
Surgical and pathological results.
Items | Neoadjuvant group (n = 23) |
Adjuvant group (n = 35) |
P value∗ |
---|---|---|---|
Margins: n (%) | |||
R0 | 19 (82.6) | 28 (80.0) | 0.807 |
R1/2 | 4 (17.4) | 7 (20.0) | |
Postoperative complication: n (%) | |||
Anastomotic leak | 1 (4.3) | 0 (0) | 0.507 |
Respiratory infection | 2 (8.7) | 3 (8.6) | |
Postoperative hemorrhage | 1 (4.3) | 1 (2.9) | |
Postoperative bowel obstruction | 0 (0) | 2 (5.7) | |
Pathological staging | |||
T-stage: n (%) | |||
T1 | 1 (4.3) | 2 (5.7) | 0.335 |
T2 | 5 (21.7) | 2 (5.7) | |
T3 | 4 (21.7) | 8 (22.9) | |
T4 | 13 (52.1) | 23 (65.7) | |
N-stage: n (%) | |||
N0 | 8 (34.8) | 2 (5.7) | 0.034 |
N1 | 3 (13.0) | 9 (25.7) | |
N2 | 4 (17.4) | 10 (28.6) | |
N3 | 8 (34.8) | 14 (40.0) | |
Number of nodes harvested: n | 16 (0–49) | 13 (3–40) | 0.886 |
Number of metastatic lymph nodes: n | 3 (0–14) | 6 (0–27) | 0.040 |
*Comparisons for categorical variables performed using chi-square test. P values for number of nodes harvested and metastatic lymph nodes were calculated by Wilcoxon test.